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Abstract
The antigen-specific immune unresponsiveness seen in bancroft-
ian filariasis was studied by examining lymphokine production
in peripheral blood mononuclear cells (PBMC) or PBMC sub-
populations from 10 patients with asymptomatic microfilaremia,
13 patients with elephantiasis and 6 normal North Americans.
In each group of patients, the kinetics of the lymphokine re-
sponse and the response to mitogens and nonparasite antigens
did not differ significantly. In marked contrast, when antigen-
induced lymphokine production was examined, most patients with
microfilaremia were unable to produce either interleukin 2 (IL-
2) or y-interferon (i.e., were nonresponders), and the few who
could (hyporesponders, generally with quite low microfilaremia
levels) did so at levels significantly less than those of patients
with elephantiasis, all of whom showed strong responses to par-
asite antigen. Removal of neither adherent cells or T8+ cells
affected the parasite-specific anergy seen in those with microfil-
aremia, suggesting a state of T cell tolerance to the parasite in
patients with this most common clinical manifestation of ban-
croftian filariasis.
Introduction
The lymphatic filariases, estimated to affect ~ 100 million people
(1), are chronic parasitic helminth infections that evoke host
immune responses that have been implicated both in resistance
to infection (2, 3) and in the pathogenesis of the different clinical
expressions of these diseases (4). The range of clinical expressions
is broad, and in both bancroftian and brugian filariasis these
include elephantiais, “filarial fevers” associated with lymphan-
gitis and lymphadenitis, the syndrome of tropical pulmonary
eosinophilia (TPE)1 and a condition in which individuals are
entirely asymptomatic yet have persistent microfilaremia. This
wide range of clinical expression is felt to reflect the diversity of
the host’s immune response to the filarial parasite (4) and, indeed,
these clinical groups can be roughly stratified on the basis of
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their immune responsiveness to the parasite or the parasite
products (3).
Several observations (5-8) suggest that distinct immunolog-
ical defects exist in patients with the asymptomatic form of the
infection (manifested by parasitemia) that could allow the par-
asite to survive “unscathed” within the host, thus assuring suc-
es ful completion of the life cycle as microfilariae are ingested
with the blood meal of vector mosquitoes. While quantitative
studies of humoral immune responses in patients with filariasis
have generally shown hyperglobulinemia with elevated levels of
antifilarial antibodies of most isotypes (3), microfilaremic indi-
viduals have consistently been found to be a subgroup of patients
wit  relatively low levels of parasite-specific antibody (6). In
vitro studies of parasite antigen-driven antibody production by
th se patients’ peripheral blood mononuclear cells (PBMC) have
indicated that a parasite-specific B cell tolerance may exist (7).
Furthermore, it has been shown that lymphocytes from patients
with asymptomatic microfilaremia (associated with either Brugia
malayi or Wuchereria bancrofti infections) fail to respond to
fil rial antigens in cellular proliferation assays though they retain
their reactivity to nonparasite antigens (9, 10). Serum suppressor
factors (9), suppressor adherent cells (assumed to be monocytes)
(9), and T-lymphocyte suppressor ceils (10) each have been im-
plicated as mediators of this parasitic-specific immunosuppres-
sion. More recently, increased numbers of T-suppressor cells
resulting in abnormally low T helper/Y suppressor ratios have
been described in filaria infected populations; and, reportedly,
both of these T cell abnormalities return to normal after suc-
ces ful treatment with diethylcarbamazine(11).
All of these studies have as their basis the notion of strict
odulation of the immune response to parasite antigen, but the
actual mechanisms underlying this immunomodulation have
not been defined. Thus, to study these mechanisms directly, we
have examined T cell responsiveness to parasite antigen (assessed
by the measurement of the lymphokines interleukin 2, IL-2, and
g - t rferon, IFN) in patients with asymptomatic microfilaremia
and then contrasted the findings to the responses in patients
with filariasis manifested by chronic lymphatic pathology. In
addition, we have evaluated the possible immunoregulatory ef-
fects of suppressor T cell and adherent cell populations. Our
results indicate that microfilaremia is associated with a state of
specific T cell anergy, manifested by an inability to generate
lymphokine, with respect to parasite antigen. Further, this anergy
cannot be overcome by removal of suppressor cell populations.
These findings point directly to the concept of an immunolog-
ically tolerant state which is parasite specific. Such tolerance is
likely important in maintaining the unique biological relation-
ship that exists between the human host and its parasites.
Methods
Study population. 23 adult volunteers living in the area of Madras, India,
where filariasis with periodic W. bancrofti is endemic were studied. After
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the purposes and methods of this investigation had been explained, study
subjects had a history and physical examination, routine hematologic
evaluation, stool examinations to exclude intestinal parasites, and a sep-
arate blood examination for circulating microfilariae. On the basis of
these findings, each individual was assigned to a clinical category. De-
termination of the levels of microfilaremia was carried out by filtering
1 ml of heparinized blood obtained between 10 p.m. and 2 a.m. through
a 3-µm filter (Nuclepore Co., Pleasanton, CA) and counting the number
of parasites on the filter after staining with Giemsa (12). Six normal
North Americans (two females, four males) ranging in age between 24
and 44 years were also studied.
Antigens and mitogens. B. malayi adult antigen (BmA) was prepared
as a saline extract of adult parasites as described and characterized pre-
viously (13). Tuberculin purified protein derivative (PPD) was obtained
from Connaught Laboratories (Toronto, Canada). Tetanus toxoid (TT)
was obtained from the Massachusetts Public Health Service (Boston,
MA). Phytohemagglutinin (PHA) was obtained from Burroughs Well-
come (Research Triangle, NC).
Microfilariae were obtained from the peritoneal cavity of jirds (Mer-
iones unguiculatus) by lavage with 25 ml of sterile Hanks’ balanced salt
solution (HBSS). Adult worms were removed, and the harvested micro-
filariae were washed twice with sterile HBSS, centrifuged, and resuspended
in C-RPMI (see below). To remove contaminating jird peritoneal in-
flammatory cells, the microfilarial suspension was incubated in a petri
dish for 45 min at 37°C, 5% CO2. The nonadherent microfilariac were
collected, overlaid on Ficoll-Diatrizoate (Bionetics, Rockville, MD), and
centrifuged at 1,750 rpm for 20 min. The microfilariae that sedimented
in the pellet were harvested and washed in C-RPMI. Any residual jird
erythrocytes were lysed by NH4Cl lysis.
Isolation of cell populations. PBMC were collected from heparinized
blood drawn mid-morning and were further purified by sedimentation
on a Hypaque-Ficoll gradient in a standard fashion (14). The PBMC
were placed in plastic petri dishes at a density of 5 x 106 cells per milliliter.
After 1 h incubation at 37°C, the nonadherent cells were collected,
washed, and further purified (see below); the adherent cells were also
collected and washed. T cell enriched fractions were obtained by twice
resetting with 2-aminoethylisothiouronium bromide (AET) treated sheep
red blood cells as described previously (15). T4 and T8 positive cells
were obtained by incubating the AET positive cells with OKT4 and
OKT8 (Ortho Pharmaceuticals, Raritan, NJ), respectively, and then ro-
setting with ox red blood cells coated with goat anti-mouse IgG (Boeringer-
Mannheim, Indianapolis, IN) as described previously (16).
Proliferation assays. PBMC or subpopulations were cultured at 1
x 105 cells/0.2 ml in round bottomed 96-well microtiter plates in RPMI
1640 (Biofluids, Rockville, MD) containing 5% fetal bovine serum (PBS),
gentamicin 80 µg/ml, and 25 µM Hepes (C-RPMI). To the wells were
added media, BmA (over a range from 0.01 to 10 µg/ml), PPD (10
µg/ml) or the mitogen PHA (10 µg/ml). All cultures were performed in
triplicate and maintained in a humidified atmosphere at 37°C with
5% CO2.
After 3 d (for mitogens) or 5 d (for antigens), 20 µl of C-RPMI
containing 1 µCi [3H]thymidine (New England Nuclear, Boston, MA)
was added to the cultures and the cells were collected on glass filters after
16 h with a Mash cell harvester (M. A. Bioproducts, Walkersville, MD).
The incorporation of thymidine was measured by liquid scintillation
spectroscopy. Data are expressed as the stimulation index (SI) obtained
by dividing the counts per minute (mean of triplicate cultures) of the
antigen or mitogen stimulated cultures by the mean counts per minute
of the control cultures.
Culture conditions for lymphokine production. Cul ures for the pro-
duction of IL-2 and g -IFN were performed in C-RPMI in 24 well tissue
culture plates (Costar, Cambridge, MA). These cultures contained 2
x 106 cells per ml (PBMC or subpopulations with 5% adherent cells)
and were incubated either with media alone or with BmA, PPD, or PHA
at 3 final concentration of 10 µg/ml. Cultures were set up in replicates,
and supernatant fluid from duplicate wells were harvested at 24, 48, and
120 h and stored at –70°C until assayed.
In one set of experiments (see below) IL-2 and g -IFN containing
supernatants were derived from PHA-stimulated PBMC. These super-
natants were then incubated with media alone or with Sepharose coupled
to either human serum albumin (HSA) or BmA at 50% vol/vol for 24
h with rotation. The supernatants were harvested after centrifugation
and ass ssed for lymphokine activity.
Assays for IL-2 and g -IFN. IL-2 was measured using the IL-2 de-
pendent HT-2 cell line as described previously (17). Data for IL-2 are
expressed in International Units, 1 U being the IL-2 concentration nec-
essa y to obtain half maximal incorporation of [3H]thymidine by the
HT-2 cells in a standard assay. g -IFN activity was determined by the
reduction in vesicular stomatitis virus plaque formation on human am-
nion (WISH) cells grown in microtiter plates (18). The antiviral activity,
expr ssed in IFN units, was calculated as the reciprocal of the highest
dilution of the sample that reduced the number of viral plaques by 50%.
Micro enzyme linked immunosorbent assay (ELISA) for parasite-
specific IgG. IgG antifilarial antibodies were measured using an ELISA
as described (19). All results are expressed as end titers all run within
the same assay.
Results
Study population. 13 individuals with chronic lymphatic ob-
struction (CP) and 10 with asymptomatic microfilaremia (MF)
were studied. Relevant demographic, parasitological and clinical
data are summarized in Table I. There were no significant dif-
ferences between the patient groups with regard to sex or age
distribution. None of the patients with microfilaremia had
symptoms referrable to filariasis. In addition, those patients with
microfilaremia had a rather broad range of numbers ofcirculating
microfilariae. Their geometric mean antifilarial antibody level
was 746 (compared to 2,409 for the patients with CP; P < 0.01 ).
Further, none of the patients with MF were able to mount a
proliferative response (SI > 2) to the filarial parasite anti-
gen, BmA.
Kin tics of antigen- and mitogen-driven IL-2 and g -IFN pro-
duction. After defining in preliminary experiments the antigen
and mitogen concentration stimulating lymphokine production
optimally (data not shown), we examined the kinetics of IL-2
and g -IFN in response. to parasite antigen (Fig. I). When patient
PBMC were stimulated with the filarial parasite antigen BmA
and the supernatant fluid tested sequentially for lymphokine
levels, antigen-driven IL-2 production was found to peak by 48
h, whereas g -IFN rose rapidly for 48 h and then more slowly
for all 5 d (120 h). Since the time course of mitogen (PHA)-
drive  IL-2 and g -IFN production paralleled that of the antigen
stimulated cultures, subsequent IL-2 and g IFN data are derived
from supernatants harvested from 2-d and 5-d cultures, respec-
tively. Further, the kinetics of both antigen- (including PPD,
TT) and mitogen-driven lymphokine production were similar
for all groups studied (data not shown).
Spontaneous IL-2 and gamma-IFN production in human
filari sis. Spontaneous lymphokine production was first ex-
amined in PBMC from all of the patients in the study population
and  he North American controls. Very few patients with
either form of filariasis produced measurable amounts of either
IL-2 or g -IFN in unstimulated cultures. 1/10 patients with MF
2/13 patients with CP, and 0/6 North Americans had sponta-
neous IL-2 production; these same three patients also produced
g -IFN spontaneously (data not shown).
Lymphokine production in response to parasite antigen,
nonparasite antigen, and mitogen. All of the patients (both those
with microfilaremia and those with chronic pathology) were able
to produce IL-2 and g -IFN in response to PHA (Fig. 2), with
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SI*
Microfilariae Antifilarial
Patient No. Diagnosis Age/Sex No. Eosinophils antibody titer Medium BMA PPD
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
CP 45/M
CP 35/M
CP 51/M
CP 52/M
CP 71/M
CP 28/F
CP 30/F
CP 55/F
CP 40/M
CP 36/M
CP 25/F
CP 42/M
CP 25/M
MF 32/F
MF 28/M
MF 41/F
MF 52/M
MF 27/M
MF 39/M
MF 25/F
MF 58/M
MF 21/M
MF 35/F
0
0
0
0
0
0
0
0
0
0
0
0
0
180
5
10
30
65
300
35
200
20
Eos/mm3
1,980 3,200 2,695 3.6 2.5
560 1,600 1,335 3.4 3.2
240 800 1,274 3.1 7.9
300 1,600 1,879 3.2 9.0
160 3,200 6,504 3.3 6.7
1,800 6,400 5,036 3.2 2.7
280 6,400 6,102 3.2 2.2
252 3,200 1,605 3.0 2.8
290 1,600 2,106 4.2 3.3
900 1,600 1,844 5.2 4.8
1,232 3,200 ND ND ND
720 12,800 ND ND ND
640 3,200 ND ND ND
0 800 1,751 1 3.2
162 800 8,590 1 3.72
300 400 2,184 1.2 4.9
280 800 4,186 1.3 2.15
1,260 800 3,190 1 6.8
1,000 400 1,695 1.5 5.2
200 1,600 ND ND ND
210 800 ND ND ND
0 1,600 ND ND ND
114 400 ND ND ND
cpm
* Optimal stimulation index-a full dose response was done to BmA (from 0.01 µg/ml to 20 µg/ml) and two concentrations were used for PPD (1
and 10 µg/ml). The stimulation index calculated at each antigen concentration and the maximal SI is given for each patient. The medium control
is included as a point of reference.
no significant difference in the ability to generate lymphokine
between these two groups. Furthermore, when responses to PPD
were examined, 7/13 patients with CP and 6/10 patients with
microfilaremia showed IL-2 production, while all of the patients
with CP and 8/10 with microfilaremia generated g -IFN in re-
sponse to PPD. Of note is that only one of the nonresponding
(to PPD) microfilaremic patients was a non-responder to BmA
(see below).
However, lymphokine production in response to BmA was
different (Fig. 3). All patients with CP were able to generate both
IL-2 and g -IFN in response to parasite antigen (BmA), but most
(6/10) of the patients with microfilaremia were unable to generate
one or both lymphokines (IL-2 and g -IFN) when stimulated
similarly. Thus, for both IL-2 and g -IFN, patients with CP pro-
duced significantly more IL-2 (P < 0.05) and g -IFN (P
< 0.01) than patients with asymptomatic microfilaremia. Inter-
estingly, the microfilariae levels in those microfilaremic patients
who did respond to BmA were among the lowest of the group
(patient numbers 15, 16, 18, and 23 in Table I), and the levels
of lymphokine produced tier BmA stimulation were signifi-
cantly less than those generated by the same patients in response
to PPD.
The effect of parasite antigen on lymphokine production in
uninfected individuals. To assure that the BmA stimulated lym-
phokine production was indeed antigen-specific, the effect of
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parasite antigen on cells obtained from normal individuals was
xamined (Table II). Parasite antigen was unable to induce IL-
2 or g -IFN production in 6 uninfected North American indi-
vidual  studied, but each patient (all previously immunized to
TT) was able to produce both IL-2 and g -IFN when stimulated
with TT.
The effect of parasite antigen or living parasites on lympho-
kine determination. To exclude the possibility that parasite an-
tigen, by itself, could influence the amount of IL-2 and g - FN
m asured in supernatant fluid, IL-2 and g IFN containing su-
pernatants were incubated with immobilized BmA (or immo-
biliz d HSA as a control), and the lymphokine concentrations
quantified (Table III). The parasite antigen had no effect on the
concentration of IL-2 or g -IFN detected in these supernatants.
Furthermore, when BmA (10 µg/ml) was assayed for intrinsic
IL-2 or g -IFN, there was no lymphokine activity found associated
with the antigen preparation (data not shown).
To assess if microfilariae or their products (excretory/secre-
tory products) interfered with the lymphokine assays, live mi-
crofilariae were added at varying concentrations (up to 100 times
the maximum concentration found in the peripheral circulation
of the study population) to lymphokine containing supernatants.
The mixture was incubated for 24 h and then the supernatant
assayed for IL-2 and g -IFN. As seen in Table IV, even at the
highest concentration, there was no significant effect of the live
-Figure 1. The kinetics of BmA antigen- (open circles) and PHA mitogen-driven (closed circles) IL-2 and g -IFN production in patients with filariasis.
The time course of the production of both IL-2 (A) and g -IFN (B) in 6 patients with chronic lymphatic obstruction is shown. The points represent
the mean U/ml±SEM of all patients studied.
microfilariae (and presumably their released products) on thepecific T-cell unresponsiveness, we examined the blood of pa-
measurement of either IL-2 or g -IFN. tients with asymptomatic microfilaremia for evidence of sup-
The effect of monocyte or T8 depletion on antigen-stimulatedpressor cells which could inhibit the response to BmA. Since
lymphokine production. T  define the mechanism of the antigen-excess numbers of OKT8+ cells in microfilaremic individuals
Figure 2. Lymphokine production ( A: IL-2; B:
g -IFN) to mitogen and nonparasite antigen in
human filariasis. Each dot represents an indi-
vidual patient. The solid horizontal lines repre-
sent the geometric means of only those who re-
sponded; the dashed lines represent the geomet-
ric means when all patients were considered.
Figure 3. Parasite antigen-driven lymphokine production in patients
with filariasis. IL-2 (A) and g -IFN (B) production in patients from
both clinical categories. Each dot represents an individual patient. The
solid horizontal lines represent the geometric means of only those who
responded: the dashed lines represent the geometric means when all
patients were considered.
had been reported previously (10), the effect of such cells in
suppression of the lymphokine response to parasite antigen was
sought. The effect of depletion of OKT8+ cells on the IL-2 re-
sponse to BmA was studied in all 10 microfilaremic patients
and the effect on the g -IFN response was evaluated in six. None
showed any significant enhancement of the lymphokine response
either to BmA (Table V) or to PPD (data not shown) after OKT8+
cell depletion.
An effort to detect suppressor monocytes in the mixed PBMC
was made by depletion of these adherent cells on plastic dishes.
Three patients with asymptomatic microfilaremia were studied
in this fashion, and no change in IL-2 production was found
(Fig. 4). Interferon production was not studied. It is interesting,
however, that these same patients did show enhancement of
Table II. Effect of Parasite Antigen on Lymphokine
Production in Normal Individuals*
Number normals Antigen IL-2 g -IFN
U / m l U / m l
6 None 0±0 O±O
BmA 0±0 0±0
TT 1.3±.15 4.5±2.6
* PBMC of six normal North Americans were cultured in the presence
of media, BmA (10 µg/ml) or TT (0.6 µg/ml) and the supernatants
were collected and assayed for IL-2 (48 h) and g -IFN ( 120 h). Data
are expressed as the mean±SE.
Table III. The Effect of Parasite Antigen
on Lymphokine Determination
IL-2* g -IFN
Medium 8.3 14
BmA-Sepharose 8.1 (98%) 13.8 (99%)
HSA-Sepharose 8.5 (102%) 12.6 (96%)
* A supernatant containing IL-2 and g -IFN was incubated alone, with
BmA or HSA coupled to Sepharose for 24 h with rotation. The super-
natants were collected and assayed for lymphokine. The data are ex-
pressed as the units per milliliter (percentage of the control [media
alone]).
their responsiveness to PPD after such adherent cell depletion.
These two findings suggest that the parasite-specific anergy to
filarial antigen cannot be reversed by removing these two sup-
pressor cell populations (at least by the methods used) and that
other mechanisms for this phenomenon must be considered.
Discussion
Specific hyporesponsiveness of T cells to filarial parasite antigens
is well documented in the microfilaremic form of infection with
the filarial parasites, W. bancrofti and B. malayi. It is manifested
as variable skin test (delayed type hypersensitivity) responses to
microfilarial antigens (20) as well as an absence of T cell prolif-
eration in vitro (5, 9, 10). However, patients exhibit responsive-
ness to mitogens and to other soluble antigens, regardless of
their inability to respond to the soluble parasite antigen BmA.
There have been recent observations suggesting that this im-
munological hyporeactivity is a result of active immuno-
suppression by either suppressor T lymphocytes (11) or mono-
cytes (9), though direct evidence for these cells causing immu-
nomodulation has been limited.
As lymphocyte blastogenic responses are merely reflections
Table IV. The Effect of Living Microfilariae
on Lymphokine Determination
Supernatant IL-2* g -IFN
Medium 4.48 (3.94-6.52) 16.25 (12.50-19.49)
Microfilariae
37,000/ml 3.63 (2.96-4.72)‡ 17.78 (13.48-23.44)
18,500/ml 4.74 (4.22-5.68) 15.49 (9.77-24.54)
9,250/ml 4.57 (3.77-5.52) 16.03 (11.88-23.17)
4,625/ml 3.46 (2.99-4. 10) 15.96 (12.67-20.09)
2,312/ml 4.29 (3.42-5.30) 15.14 (11.75-20.42)
1,156/ml 4.58 (4.10-5.78) 18.03 (13.74-23.66)
575/ml 3.43 (3.01-3.91) 15.92 (12.65-20.05)
289/ml 3.46 (3.53-4.37) 14.9 (11.84-18.76)
* Microfilariae were added in decreasing concentrations to superna-
tants containing IL-2 and g -IFN and incubated for 24 h at 37°C. 5%
CO2. The supernatants were then collected and assayed for IL-2 and
g -IFN.The data are expressedas the geometric mean units/milliliter
(95% confidence interval).
‡ All values not significantly different from medium control value.
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Table V. Effect of Removing OKT8+ T Cells
on the Parasite-antigen Driven Lymphokine
Production in Patients with Microfilaremia
IL-2
AET+
U/ml
g -IFN
OKT8 depleted AET+ OKT8 depleted
U/ml U/ml U/ml
0 0
1.05 0.9
0.3 0.3
0 0
0.2 0.4
0 0
0 0
0 0
0 0
0.2 0.15
0 0
10 8
3 2.8
0 0
8 11
0 0
ND ND
ND ND
ND ND
ND ND
of the total PBMC population’s ability to respond proliferatively
regardless of which subpopulation initiates the proliferative re-
sponse, the present study examined more directly the T cell
dependent mechanisms of immune responsiveness to parasite
antigen of both patients with chronic disease and those with
asymptomatic microfilaremia. In this regard, when lymphokine
production (either IL-2 or g -IFN) was examined, one could see
evidence for strict T-cell unresponsiveness to parasite antigen
in most patients who were clinically asymptomatic despite high
levels of circulating microfilariae. These findings contrasted with
those from patients with chronic lymphatic obstruction whose
T cells, without exception, were able to produce lymphokines
after stimulation with filarial antigen. This observation lends
further support to the hypothesis that the host immune response
Figure 4. The effect of monocyte depletion on antigen-driven IL-2
production in microfilaremic filariasis, IL-2 production in response to
BmA (left) and PPD (right) in unfractionated (UNFX) or monocyte
depleted cell populations. Each pair of closed circles represents an in-
dividual with microfilaremia.
is important in the pathogenesis of the manifestations of chronic
disease. Additionally, the present study identifies an intermediate
group of patients who tend to be parasite-antigen hyporesponders
in contrast to nonresponding microfilaremic individuals and the
fully responsive amicrofilaremic patients (CP).
Although there have been isolated reports of defective lym-
phokine production in several parasitic protozoal diseases of
humans such as visceral leishmaniasis (21) and malaria (22) as
well as the mycobacterial disease leprosy (the lepromatous form
[23]), our findings extend to the multicellular helminth organisms
the idea that the host-parasite interaction at an immunological
level is likely responsible for the clinical outcome of the infection.
Most intriguing remains the observation, that it is the state of
microfilaremia that isas ociated with the parasite-specific anergy
seen. Since both parasites and circulating soluble parasite anti-
gens can be detected in these hyporeactive patients (24, 25),
their contribution must be taken into account in terms of im-
munoregulation. Though it is well established that sera from
microhlaremic patients or animals can inhibit cell adherence
and in vitro cytotoxicity to microfilariae (26), whether the re-
sponsible immunomodulatory factors are parasite-derived re-
mains to be elucidated. While circulating parasite antigens have
been identified in the serum of some amicrofilaremic as well as
all microfilaremic individuals, their chemical nature remains
unclear. However, there has been some recent suggestion that
these parasite antigens have immunosuppressive effects on some
mitogen-driven immune responses (Piessens, W. F., personal
communication). Of even greater interest, however, is the pos-
sibility that parasite-specific tolerance is induced by transpla-
cental transfer of microfilariae or other parasite antigens from
infected mothers. Though not direct evidence, work done on
the phenomenon of sensitization in utero has indicated that an-
tifilarial antibodies of isotypes that do not cross the placenta
(e.g., IgE and IgM) have been found in the cord blood of ap-
proximately half of the babies born of infected mothers (27) or
in the cord sera of several babies born in a region endemic for
W. bancrofti (28). Thus, for a group of individuals, the environ-
mental factors surrounding their birth may be of critical im-
portance in determining how or whether they subsequently re-
spond to filarial infection.
Our findings in the asymptomatic microfilaremic patients
help clarify the deficiencies already described in the parasite an-
tigen-induced cell-mediated immune responses of these indi-
viduals. Peripheral blood T cells from amicrofilaremic patients
with chronic lymphatic obstruction (CP) proliferated and re-
leased IL-2 and g -IFN in response to BmA in vitro, whereas
patients judged to be asymptomatic and microfilaremic fell into
two discrete groups. The majority (6/10) were unable to generate
any demonstrable lymphokine response (nonresponders)
whereas the remainder were hyporesponders. This situation is
analogous to findings in lepromatous leprosy where antigen-spe-
cific non- and hyporesponders actually reflect two different sub-
populations of patients (29). Further, these kinds of observations
may help to account for the variety of clinical conditions seen
in lymphatic filariasis and also lend validity to the notion that
the clinical manifestations of this condition are on a continuum
from entirely asymptomatic to extremely symptomatic.
More importantly, the experiments in which specific cell
populations were depleted indicated that the parasite specific
anergy seen among the patients with asymptomatic microfilare-
mia could not be overcome by the removal of either OKT8+ T
cells or monocytes. While OKT8+ cells in some pathological
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states such as systemic lupus erythematosus (SLE) (30) and per-
haps some forms of leprosy (23) have been shown to regulate
IL-2 and thereby g -IFN production, a significant body of data
points to a more complex immunoregulatory network than
merely OKT4/OKT8 interactions. The present study as well as
one study performed on patients with the lepromatous form of
leprosy (29) indicate that the OKT8+ population alone is not
responsible for the nonresponsive state seen among these patient
groups. In view of the recent reports regarding OKT4+ subpop-
ulations with different functions, perhaps examining the role of
the 2H4+ cells (31) as an inducer ofsuppression for the antigen-
driven T cell responses in microfilaremia should be an important
further study. Also, as Leu7+ cells have been shown to regulate
lymphokine production in certain disease states (e.g., SLE [30]),
the role of this cell population in lymphatic filariases remains
to be evaluated.
Monocyte suppressor activity also appears not to explain the
parasite antigen-specific anergy in our microfilaremic patients
since monocyte suppression could be demonstrated only for the
response to PPD and not tit all for the response to BmA. Thus,
it is still unclear what the controlling factors involved in the
immunological reactivity to parasite antigen really are, whether
exogenous suppressor mechanisms or endogenous antigen tol-
erance.
Epidemiological studies in areas where filariasis is endemic
have revealed differential susceptibilities to infection both within
the entire population as well as within families studied. Though
the potential immunologic cause of this difference in suscepti-
bility has not been investigated except for one study in mice
(32) and one in man (33), work done with filaria-specific T cell
clones (19) as well as with other parasites has implicated in part
the major histocompatibility complex (MHC). The specific in-
volvement of the MHC loci in regulating the host response in
lymphatic filariasis is currently being evaluated.
Finally, this study clearly indicates the usefulness of looking
beyond lymphocyte proliferation when evaluating immunoreg-
ulatory issues in diseases such as filariasis. While our observations
do not provide information on the induction of a tolerant state
in filarial parasitic infections, studies carried out with T cells
from patients with influenza virus infection (34) point to the
possibility that in vitro models for immune tolerance to any
infectious pathogen may be developed. With these and other
tools, the regulatory aspects of the immune responses to parasites
and parasite antigen should be able to be dissected so that possible
targets can be identified for modulating the host response and,
thus, the nature of disease in filaria-infected individuals.
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